683
Views
144
CrossRef citations to date
0
Altmetric
Review

Clinical assessment and treatment of attention deficit hyperactivity disorder in adults

Pages 525-539 | Published online: 10 Jan 2014

References

  • Asherson P, and the Image Consortium. Attention-deficit hyperactivity disorder in the post-genomic era. Eur. Child Adolesc. Psychiatry 13(Suppl. 1), 150–170 (2004).
  • Faraone SV, Biederman J, Spencer T et al. Attention-deficit/hyperactivity disorder in adults: an overview. Biol. Psychiatry 48, 9–20 (2000).
  • Biederman J, Faraone SV, Spencer T et al. Patterns of psychiatric comorbidity, cognition and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am. J. Psychiatry 150, 1792–1798 (1993).
  • Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M. Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Arch. Gen. Psychiatry 50, 565–576 (1993).
  • Taylor E, Chadwick O, Heptinstall E, Danckaerts M. Hyperactivity and conduct problems as risk factors for adolescent development. J. Am. Acad. Child Adolesc. Psychiatry 35, 1213–1226 (1996).
  • Kooij JJ, Aeckerlin LP, Buitelaar JK. Functioning, comorbidity and treatment of 141 adults with attention deficit hyperactivity disorder (ADHD) at a psychiatric out-patients’ department. Ned. Tijdschr. Geneeskd 145, 1498–1501 (2001).
  • Weiss M, Murray C. Attention deficit hyperactivity disorder in adults. Can. Med. Assoc. J. 168, 715–722 (2003).
  • Hill JC, Schoener EP. Age-dependent decline of attention deficit hyperactivity disorder. Am. J. Psychiatry 153, 1143–1146 (1996).
  • Biederman J, Mick E, Faraone SV. Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. Am. J. Psychiatry 157, 816–818 (2000).
  • Fischer M, Barkley RA, Smallish L, Fletcher K. Young adult follow-up of hyperactive children: self-reported psychiatric disorders, comorbidity, and the role of childhood conduct problems and teen CD. J. Abnorm. Child Psychol. 30, 463–475 (2002).
  • Rasmussen P, Gillberg C. Natural outcome of ADHD with developmental co-ordination disorder at age 22 years: a controlled, longitudinal, community-based study. J. Am. Acad. Child Adolesc. Psychiatry 39, 1424–1431 (2000).
  • Faraone SV, Biederman J, Monuteaux MC. Toward guidelines for pedigree selection in genetic studies of attention deficit hyperactivity disorder. Genet. Epidemiol. 18, 1–16 (2000).
  • Faraone SV, Spencer T, Aleardi M, Pagano C, Biederman J. Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J. Clin. Psychopharmacol. 24, 24–29 (2004).
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition, text revision. American Psychiatric Association, Washington, DC, USA (2000).
  • Todd RD, Rasmussen ER, Neuman RJ et al. Familiality and heritability of subtypes of attention deficit hyperactivity disorder in a population sample of adolescent female twins. Am. J. Psychiatry 158, 1891–1898 (2001).
  • World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. World Health Organization, Geneva, Switzerland (1993).
  • Applegate B, Lahey BB, Hart EL et al. Validity of the age-of-onset criterion for ADHD: a report from the DSM-IV field trials. J. Am. Acad. Child Adolesc. Psychiatry 36, 1211–1221 (1997).
  • Barkley RA, Biederman J. Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 36, 1204–1210 (1997).
  • Barkley RA, Fischer M, Smallish L, Fletcher K. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J. Abnorm. Psychol. 111, 279–289 (2002).
  • Brown TE. Brown ADD scale diagnostic form. In: Brown Attention-Deficit Disorder Scales. The Psychological Corporation, TX, USA (1996).
  • Epstein J, Johsnon D, Conners CK. Conners Adult ADHD Diagnostic Interview for DSM-IV (CAADID). Multi Health Systems, Inc., NY, USA (1999).
  • Robins LN, Helzer JE, Croughan J, Ratcliff KS. National Institute of Mental Health diagnostic interview schedule. Its history, characteristics, and validity. Arch. Gen. Psychiatry 38, 381–389 (1981).
  • Barkley RA, Murphy K. Attention-Deficit Hyperactivity Disorder. A Clinical Workbook. The Guilford Press, NY, USA (1998).
  • Conners CK. Rating scales in attention-deficit/hyperactivity disorder: use in assessment and treatment monitoring. J. Clin. Psychiatry 59(Suppl. 7), 24–30 (1998).
  • Kessler RC, Adler L, Ames M et al. The World Health Organization adult ADHD self-report scale (ASRS): a short screening scale for use in the general population. Psychol. Med. 35, 245–256 (2005).
  • Ward MF, Wender PH, Reimherr FW. The WURS: a rating scale to aid in the retrospective diagnosis of attention deficit disorder in childhood. Am. J. Psychiatry 150, 885–890 (1993).
  • Castellanos FX, Tannock R. Neuroscience of attention-deficit hyperactivity disorder: the search for endophenotypes. Nature Rev. Neurosci. 3, 617–628 (2002).
  • Kuntsi J, Asherson P. An interdisciplinary approach to ADHD. Attention Deficit Hyperacivity Disorder Research Developments. Nova Science Publishers, Inc, NY, USA, 1–30 (2004).
  • Hervey AS, Epstein JN, Curry JF. Neuropsychology of adults with attention-deficit/hyperactivity disorder: a meta-analytic review. Neuropsychology 18, 485–503 (2004).
  • Asherson P, Kuntsi J, Taylor E. Unraveling the complexity of ADHD: a behavioral genomic approach. Br. J. Psychiatry (2005) (In Press).
  • Schachter HM, Pham B, King J, Langford S, Moher D. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. Can. Med. Assoc. J. 165, 1475–1488 (2001).
  • Kooij JJ, Burger H, Boonstra AM, Van der Linden PD, Kalma LE, Buitelaar JK. Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder. A randomized, placebo-controlled, double-blind, cross-over trial. Psychol. Med. 34, 973–982 (2004).
  • Spencer T, Biederman J, Wilens T et al. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol. Psychiatry 57, 456–463 (2005).
  • Spencer T, Biederman J, Wilens T et al. A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol. Psychiatry 57(5), 456–463 (2005).
  • Simpson D, Plosker GL. Spotlight on atomoxetine in adults with attention-deficit hyperactivity disorder. CNS Drugs 18, 397–401 (2004).
  • Michelson D, Adler L, Spencer T et al. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol. Psychiatry 53, 112–120 (2003).
  • Adler LA, Spencer TJ, Milton DR, Moore RJ, Michelson D. Long-term, open-label study of the safety and efficacy of atomoxetine in adults with attention-deficit/hyperactivity disorder: an interim analysis. J. Clin. Psychiatry 66, 294–299 (2005).
  • Wilens TE, Spencer TJ, Biederman J. A review of the pharmacotherapy of adults with attention-deficit/hyperactivity disorder. J. Atten. Disord. 5, 189–202 (2002).
  • Wilens TE, Hammerness PG, Biederman J et al. Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder. J. Clin. Psychiatry 66, 253–259 (2005).
  • Wilens TE, Haight BR, Horrigan JP et al. Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study. Biol. Psychiatry 57, 793–801 (2005).
  • Hesslinger B, Tebartz van Elst L, Nyberg E et al. Psychotherapy of attention deficit hyperactivity disorder in adults – a pilot study using a structured skills training program. Eur. Arch. Psychiatry Clin. Neurosci. 252, 177–184 (2002).
  • Stevenson CS, Whitmont S, Bornholt L, Livesey D, Stevenson RJ. A cognitive remediation programme for adults with attention deficit hyperactivity disorder. Aust. NZ. J. Psychiatry 36, 610–616 (2002).
  • Wilens T, McDermott S. Cognitive therapy for adults with ADHD. In: Attention Deficit Disorders and Comorbidities in Children, Adolescents and Adults. Brown TE (Ed.), American Psychiatric Press, WA, USA, 569–607 (2000).
  • Biederman J, Mick E, Faraone SV, Van Patten S, Burback M, Wozniak J. A prospective follow-up study of pediatric bipolar disorder in boys with attention-deficit/hyperactivity disorder. J. Affect. Disord. 82(Suppl. 1), S17–S23 (2004).
  • Kent L, Craddock N. Is there a relationship between attention deficit hyperactivity disorder and bipolar disorder? J. Affect. Disord. 73, 211–221 (2003).
  • Wilens TE, Biederman J, Wozniak J, Gunawardene S, Wong J, Monuteaux M. Can adults with attention-deficit/hyperactivity disorder be distinguished from those with comorbid bipolar disorder? Findings from a sample of clinically referred adults. Biol. Psychiatry 54, 1–8 (2003).
  • Wilens TE, Faraone SV, Biederman J, Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 111, 179–185 (2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.